First- and second-generation antipsychotics.
Publication
, Journal Article
McEvoy, JP; Zigman, D; Margolese, HC
Published in: Can J Psychiatry
March 2010
Duke Scholars
Published In
Can J Psychiatry
DOI
EISSN
1497-0015
Publication Date
March 2010
Volume
55
Issue
3
Start / End Page
144 / 148
Location
United States
Related Subject Headings
- Schizophrenia
- Psychotic Disorders
- Psychiatry
- Humans
- Clinical Trials as Topic
- Antipsychotic Agents
- 5203 Clinical and health psychology
- 3202 Clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
McEvoy, J. P., Zigman, D., & Margolese, H. C. (2010). First- and second-generation antipsychotics. Can J Psychiatry, 55(3), 144–148. https://doi.org/10.1177/070674371005500305
McEvoy, Joseph P., Daniel Zigman, and Howard C. Margolese. “First- and second-generation antipsychotics.” Can J Psychiatry 55, no. 3 (March 2010): 144–48. https://doi.org/10.1177/070674371005500305.
McEvoy JP, Zigman D, Margolese HC. First- and second-generation antipsychotics. Can J Psychiatry. 2010 Mar;55(3):144–8.
McEvoy, Joseph P., et al. “First- and second-generation antipsychotics.” Can J Psychiatry, vol. 55, no. 3, Mar. 2010, pp. 144–48. Pubmed, doi:10.1177/070674371005500305.
McEvoy JP, Zigman D, Margolese HC. First- and second-generation antipsychotics. Can J Psychiatry. 2010 Mar;55(3):144–148.
Published In
Can J Psychiatry
DOI
EISSN
1497-0015
Publication Date
March 2010
Volume
55
Issue
3
Start / End Page
144 / 148
Location
United States
Related Subject Headings
- Schizophrenia
- Psychotic Disorders
- Psychiatry
- Humans
- Clinical Trials as Topic
- Antipsychotic Agents
- 5203 Clinical and health psychology
- 3202 Clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences